INTRODUCTION

Atrial natriuretic peptide (ANP)
1 is a hormone produced in the cardiac atrium and secreted into the circulation in response to atrial distension. ANP stimulates salt excretion (1) and dilates arterial vessels (2, 3) . Through these activities, ANP plays a major role in the regulation of blood pressure and salt-fluid volume homeostasis. Transgenic animals devoid of the ANP gene develop salt-sensitive hypertension (4) , and those lacking the ANP receptor gene develop salt-insensitive essential hypertension accompanied by severe cardiac hypertrophy, fibrosis, and dilatation (5),
implicating the ANP and ANP receptor systems in cardiovascular pathophysiology. An analogous hormone, B-type natriuretic peptide (BNP), is also produced and secreted mainly by the heart and has hormonal activities similar to ANP (6) involve a large buried surface area (1,680 Å 2 and 1,100 Å 2 , respectively) and multiple residues contacts. Thus, from the crystallographic data alone, it has not been possible to distinguish which dimer form represents the physiological ANP receptor dimer structure. We have recently reported site-directed mutagenesis studies of the residues involved in the two possible dimer interfaces in the full-length ANP receptor expressed on COS cells. We have found that certain mutations at the head-to-head dimer interface cause the receptor to become either uncoupled or constitutively GCase-active, while mutations at the tail-to-tail dimer interface cause no such effect (21). These results strongly suggest that the extracellular domain of the native ANP receptor on the cell surface assumes the head-to-head dimer structure and that the tail-to-tail dimer previously described represents an artificial crystallographic dimer pair occurring in the crystal packing of apoANPR. The head-to-head dimer structure for the apoANPR is similar to that proposed for the extracellular domain of the natriuretic peptide clearance-receptor (22).
In the present study, we have determined the crystal structure of the ANPR complexed with the hormone ANP. The comparison of the complex structure, also occurring in the head-to-head configuration, with the unbound structure reveals a structural change caused by ANP binding and suggests a structural basis for transmembrane signaling by the ANP receptor.
6 chromatography. The complex of the ANPR (10 mg/ml) and an ANP peptide consisting of residues 7 through 27 (sequence: Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-GlyLeu-Gly-Cys-Asn-Ser-Phe-Arg) was crystallized by hanging-drop vapour diffusion at room temperature with 1.6 M to 2.0 M ammonium sulfate in 0.1 M MES buffer, pH 6.5, containing 10 mM NaCl. These conditions differ from those used for crystallizing the apoANPR. Crystals were dialyzed against high concentration of ammonium sulfate solution and were frozen in liquid propane. The crystals had the space group of P6 1 with unit cell parameters a = 100.1 Å, b = 100.1 Å, and c = 259.8 Å. Two ANPR molecules are present in an asymmetric unit with a V M (Mathews coefficient) of 3.9 Å 3 /dalton. Data were collected at 100 K at Advanced Photon Source beamline 19-ID, and National Synchrotron Light Source beamlines X4A and X25. Data were processed and scaled using the HKL package (24).
Structure Determination and Refinement-The structure was solved by molecular replacement with the program CNS (25) using one ANPR molecule in the apoANPR dimer structure (PDB accession number 1DP4) as the search model (Table I) . Molecular replacement calculations were also performed using the individual membrane-proximal and membrane-distal domains as the model, which gave essentially the same structure. assigned. The stereochemistry of the final structure was analysed with PROCHECK (27).
Assignment of the secondary structures was done using program DSSP (28).
RESULTS AND DISCUSSION
Overall Structure of the ANPR-ANP Complex-The extracellular hormone-binding domain of the ANP receptor (ANPR) consisting of residues 1-435 was expressed and purified as described (16) . ANPR was crystallized with an ANP peptide with the sequence Cys-Phe-GlyGly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg (Cys 7 and Cys 23 are disulfide-bonded) representing ANP residues 7 through 27 (23). This peptide is fully hormonally active (29,30). The structure of ANP-bound receptor complex (Fig. 1a ) was determined to 2.95 Å resolution (Table I) (19) . The two ANPR monomers, also related by non-crystallographic two-fold symmetry, form a head-to-head dimer through their membrane-distal domains (Fig. 1a) . ANP-induced Structure Changes-To examine the structural basis for ANP receptor signaling, the structure of the ANP-bound ANPR dimer complex (Fig. 1a) was compared with that of the apoANPR dimer (Fig. 1b) . The ANP-induced structural change involves a shift in the relative positions of the two ANPR monomers as shown in Fig. 2 (also shown in Supplemental Animation S2). There is no appreciable intra-molecular conformational change in each individual ANPR monomer (root mean square deviation of C , 0.64 Å) (Fig. 3a) . Upon ANP binding, the two ANPR molecules undergo a twist motion centered on a fulcrum point O ( "open" at the flexible intra-molecular hinge connecting the membrane-distal and membraneproximal domains (Fig. 3b ). This bending causes the membrane-proximal domain to swing onto the bound ligand, leaving the membrane-distal domain and its dimerized structure essentially unchanged (Supplemental Fig. S3 ). This motion approximates the two membrane-proximal domains but does not change their relative orientation. Unlike the ANP receptor, the clearancereceptor lacks the GCase domain (10) and is not known to mediate any of the known hormonal activities of natriuretic peptides. The clearance-receptor binds ANP, BNP, and CNP as well as some of their biologically inactive fragments with equally high affinity in order to remove the excess of these peptides from the circulation (11, 12) . The difference in the ligand-induced motion in the ANP receptor from that in the clearance-receptor may reflect the fact that the ANP receptor mediates hormonal signaling whereas the clearance-receptor effects metabolic clearance. Additionally, the conformational flexibility at the intra-molecular hinge in the clearance-receptor (22) may be responsible for its broad ligand specificity.
Dimer Interface Structure-At the dimer interface in the apoANPR structure ( Table S1 -3). Buried surface areas at the two sites are nearly equal (1,374 Å 2 and 1,367 Å 2 for sites A and B, respectively), suggesting significant contributions of both sites to hormone binding. The surface structures of both sites A and B have a ring-shaped groove lined with polar residues (Fig. 5b, c) . ANP fits closely into the groove at both sites, consistent with the high ligand specificity of the ANP receptor. Upon binding, ANP Table S1 -3). The Cterminal segment of ANP (residues Asn 24(ANP) through Arg 27(ANP)) runs parallel with a stretch of -sheet in the ANPR (residues Gln186B through Phe188B), and a hydrogen bond occurs between Asn 24(ANP) carbonyl oxygen and Glu 187B amide nitrogen, suggesting partial formation of a parallel -sheet (Fig. 5a ). An additional hydrogen bond occurs between Asn 24(ANP) and His185B. These interactions are consistent with the finding that the C-terminal residues of ANP are necessary for receptor binding and hormonal activities (30). The agreement found here between the ANP residues involved in binding and the structure-activity relationship for ANP (30) confirms the assigned ANP peptide structure in the complex and, at the same time,
suggests that the crystal structure of this complex closely reflects the structure of the native ANP receptor bound with ANP.
ANP residues contributing to binding to the receptor are all conserved in BNP, including Arg14, Phe8, Asp24 (Asn24 in ANP), and Arg24 (Supplemental Fig. S1 e) . The conservation of these critical residues suggests that the mechanism of BNP binding to this receptor as well as the resulting structural change in the receptor may be similar to those described here for ANP. The ANP receptor binds ANP and BNP with high affinity but shows weak affinity to CNP (16) . The weak affinity to CNP, which lacks C-terminal residues (Supplemental Fig. S1 e), may be due to its inability to form this interaction. (Fig. 6b, inset) . Earlier, Koshland and colleagues postulated models for transmembrane signaling mechanism that depended on the hypothetical motion in the transmembrane region (32) . Their models included association, dissociation, piston, rotation, scissor, and seesaw models. The ANP-induced motion of the juxtamembrane domains in the ANP receptor corresponds closely to the rotation mechanism postulated by these investigators (shown schematically in Fig. 6b, inset) . (Fig. 2c, Fig. 6b ). Instead, ANP binding causes a large 24° rotation of each of the two juxtamembrane domains, altering their relative orientations (Fig. 6b) . In the intact ANP receptor, this hormone-induced rotation of the juxtamembrane domains, transduced through the transmembrane helices, may reorient the relative positions (or configuration) of the intracellular domains to cause GCase activation (Fig. 7) .
The ANPR expressed in a soluble form lacks the transmembrane and intracellular domains and, for this reason, its apo and ANP-bound structures may not accurately reflect those of the native full-length receptor in the cell membrane. Nevertheless, we have shown earlier that the effects of mutations at the dimer interface in the full-length receptor on COS cells are consistent optimal proximity and orientation, thereby giving rise to GCase catalytic activity (Fig. 7) .
The rotation mechanism initiating transmembrane signaling by the ANP receptor uncovered in the present study represents to our knowledge the first such mechanism identified for any Binding causes the membrane proximal-domain to swing in by 13°t oward the bound peptide, while the dimerized structure of the membrane-distal domains remains essentially unchanged. The models were drawn using the coordinates at the Protein Data Bank (PDB accession numbers 1JDP and 1JDN for the CNP-bound and unbound forms of clearancereceptor extracellular domain, respectively).
